Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases

被引：168

作者：

Catala, A. ^{[1
]}

Munoz-Santos, C. ^{[2
]}

Galvan-Casas, C. ^{[3
]}

Roncero Riesco, M. ^{[4
]}

Revilla Nebreda, D. ^{[4
]}

Sola-Truyols, A. ^{[5
]}

Giavedoni, P. ^{[1
]}

Llamas-Velasco, M. ^{[6
]}

Gonzalez-Cruz, C. ^{[7
]}

Cubiro, X. ^{[8
]}

Ruiz-Villaverde, R. ^{[9
]}

Gomez-Armayones, S. ^{[1
]}

Gil Mateo, M. P. ^{[10
]}

Pesque, D. ^{[11
]}

Marcantonio, O. ^{[11
]}

Fernandez-Nieto, D. ^{[12
]}

Romani, J. ^{[13
]}

Iglesias Pena, N. ^{[14
]}

Carnero Gonzalez, L. ^{[15
]}

Tercedor-Sanchez, J. ^{[16
]}

Carretero, G. ^{[17
]}

Masat-Tico, T. ^{[18
]}

Rodriguez-Jimenez, P. ^{[6
]}

Gimenez-Arnau, A. M. ^{[11
]}

Utrera-Busquets, M. ^{[19
]}

Vargas Laguna, E. ^{[20
]}

Angulo Menendez, A. G. ^{[21
]}

San Juan Lasser, E.

Iglesias-Sancho, M. ^{[22
]}

Alonso Naranjo, L. ^{[23
]}

Hiltun, I ^{[24
]}

Cutillas Marco, E. ^{[25
]}

Polimon Olabarrieta, I ^{[3
]}

Marinero Escobedo, S. ^{[3
]}

Garcia-Navarro, X. ^{[26
]}

Calderon Gutierrez, M. J.

Baeza-Hernandez, G. ^{[27
]}

Bou Camps, L.

Toledo-Pastrana, T. ^{[28
]}

Guilabert, A. ^{[2
]}

机构：

[1] Hosp Clin Barcelona, Serv Dermatol, Barcelona, Spain

[2] Hosp Gen Granollers, Serv Dermatol, Barcelona, Spain

[3] Hosp Univ Mostoles, Serv Dermatol, Madrid, Spain

[4] Complejo Asistencial Univ Salamanca, Serv Dermatol, Salamanca, Spain

[5] Hosp Univ Son Llatzer, Serv Dermatol, Mallorca, Spain

[6] Hosp Univ La Princesa, Serv Dermatol, Madrid, Spain

[7] Hosp Univ Vall DHebron, Serv Dermatol, Barcelona, Spain

[8] Hosp Santa Creu & Sant Pau, Serv Dermatol, Barcelona, Spain

[9] Hosp Univ San Cecilio, Serv Dermatol, Granada, Spain

[10] Hosp Gen La Palma, Serv Dermatol, Santa Cruz De Tenerife, Spain

[11] Univ Autonoma Barcelona, IMIM, Hosp Mar, Serv Dermatol, Barcelona, Spain

[12] Hosp Raman & Cajal, Serv Dermatol, Madrid, Spain

[13] Parc Tauli Hosp Univ, Serv Dermatol, Barcelona, Spain

[14] Hosp Univ Lucus Augusti, Serv Dermatol, Lugo, Spain

[15] Hosp Univ Araba, Serv Dermatol, Vitoria, Spain

[16] Hosp Virgen de las Nieves, Serv Dermatol, Granada, Spain

[17] Hosp Univ Gran Canaria Doctor Negrin, Serv Dermatol, Las Palmas Gran Canaria, Spain

[18] Inst Catala Salut, CAP Cardedeu, Barcelona, Spain

[19] Hosp Comarcal Infanta Elena, Serv Dermatol, Huelva, Spain

[20] Hosp Univ Severo Ochoa, Serv Dermatol, Madrid, Spain

[21] Serv Med Penedes Vilanova & Geltru, Serv Dermatol, Barcelona, Spain

[22] Hosp Univ Sagrat Cor, Serv Dermatol, Madrid, Spain

[23] Hosp Univ Toledo, Serv Dermatol, Toledo, Spain

[24] Complejo Hosp Navarra, Serv Dermatol, Navarra, Spain

[25] Hosp Gen Univ Reina Sofia, Serv Dermatol, Murcia, Spain

[26] Consorci Sanitari Alt Penedes Garraf, Serv Dermatol, Barcelona, Spain

[27] Hosp Univ Fuenlabrada, Serv Dermatol, Madrid, Spain

[28] Hosp Quironsalud Infanta Luisa, Seville, Spain

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 01期

关键词：

COVID-19; VACCINATION;

D O I：

10.1111/bjd.20639

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background Cutaneous reactions after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are poorly characterized. Objective To describe and classify cutaneous reactions after SARS-CoV-2 vaccination. Methods A nationwide Spanish cross-sectional study was conducted. We included patients with cutaneous reactions within 21 days of any dose of the approved vaccines at the time of the study. After a face-to-face visit with a dermatologist, information on cutaneous reactions was collected via an online professional survey and clinical photographs were sent by email. Investigators searched for consensus on clinical patterns and classification. Results From 16 February to 15 May 2021, we collected 405 reactions after vaccination with the BNT162b2 (Pfizer-BioNTech; 40 center dot 2%), mRNA-1273 (Moderna; 36 center dot 3%) and AZD1222 (AstraZeneca; 23 center dot 5%) vaccines. Mean patient age was 50 center dot 7 years and 80 center dot 2% were female. Cutaneous reactions were classified as injection site ('COVID arm', 32 center dot 1%), urticaria (14 center dot 6%), morbilliform (8 center dot 9%), papulovesicular (6 center dot 4%), pityriasis rosea-like (4 center dot 9%) and purpuric (4%) reactions. Varicella zoster and herpes simplex virus reactivations accounted for 13 center dot 8% of reactions. The COVID arm was almost exclusive to women (95 center dot 4%). The most reported reactions in each vaccine group were COVID arm (mRNA-1273, Moderna, 61 center dot 9%), varicella zoster virus reactivation (BNT162b2, Pfizer-BioNTech, 17 center dot 2%) and urticaria (AZD1222, AstraZeneca, 21 center dot 1%). Most reactions to the mRNA-1273 (Moderna) vaccine were described in women (90 center dot 5%). Eighty reactions (21%) were classified as severe/very severe and 81% required treatment. Conclusions Cutaneous reactions after SARS-CoV-2 vaccination are heterogeneous. Most are mild-to-moderate and self-limiting, although severe/very severe reactions are reported. Knowledge of these reactions during mass vaccination may help healthcare professionals and reassure patients.

引用

页码：142 / 152

页数：11

共 50 条

[1] Mental health outcomes after SARS-CoV-2 vaccination in the United States: A national cross-sectional study
Chen, Shanquan
Aruldass, Athina R.
Cardinal, Rudolf N.
JOURNAL OF AFFECTIVE DISORDERS, 2022, 298 : 396 - 399
[2] Executive deficits after SARS-CoV-2 infection: A cross-sectional population study
Buer, S.
Hagen, B. I.
Soraas, A.
White, R. A.
Bo, R.
Ellingjord-Dale, M.
Istre, M. S.
Brunvoll, S. H.
Lerdal, A.
Landro, N. I.
Nygaard, A. B.
Stubberud, J.
BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2024, 41
[3] Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study
Nah, Eun-Hee
Cho, Seon
Park, Hyeran
Hwang, Inhwan
Cho, Han-Ik
BMJ OPEN, 2021, 11 (04):
[4] Hesitancy to Undergo SARS-CoV-2 Rapid Antigen Testing in China: Nationwide Cross-sectional Study
Lu, Zhen
Fu, Leiwen
Yang, Luoyao
Tian, Tian
Gao, Yanxiao
Meng, Xiaojun
Zou, Huachun
JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
[5] Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
Cao, Yanlin
Li, Juan
Ma, Yuan
Suo, Luodan
Li, Xiaomei
Xu, Mingyu
Wu, Jiang
Yang, Weizhong
Feng, Luzhao
Ni, Jing
CHINESE MEDICAL JOURNAL, 2023, 136 (18) : 2263 - 2265
[6] Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
Cao Yanlin
Li Juan
Ma Yuan
Suo Luodan
Li Xiaomei
Xu Mingyu
Wu Jiang
Yang Weizhong
Feng Luzhao
中华医学杂志英文版, 2023, 136 (18)
[7] Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study
Mascitti, Helene
Bonsang, Benjamin
Dinh, Aurelien
Assan, Florence
Perronne, Veronique
Leblanc, Thibault
Duran, Clara
Bouchand, Frederique
Matt, Morgan
Le Gal, Aurelie
Van Thanh, Julia N'guyen
Lanore, Aymeric
Jacob, Louis
Kiavue, Nicolas
Simeon, Soline
Bessis, Simon
de Truchis, Pierre
Landowski, Stephanie
Davido, Benjamin
Moreau, Frederique
Rameix-Welti, Marie-Anne
Gault, Elyanne
Gaillard, Jean-Louis
Roux, Anne-Laure
Sivadon-Tardy, Valerie
Salomon, Elsa
El Sayed, Faten
Carlier, Robert
Emile, Jean-Francois
Perronne, Christian
Bourgault-Villada, Isabelle
OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (11):
[8] Factors associated with SARS-CoV-2 vaccine hesitancy after stroke: a cross-sectional study
Hu, Peng
Zhu, Ying-Hai
Bai, Chuan-Chuan
Wang, Wei
Li, Duo
Cao, Lei
Huang, Yan-Qing
Heng, Tian
Zhou, Xiao-Han
Liu, Tao
Luo, Ya-Xi
Yao, Xiu-Qing
BMC PUBLIC HEALTH, 2024, 24 (01)
[9] Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Anand, Shuchi
Montez-Rath, Maria
Han, Jialin
Bozeman, Julie
Kerschmann, Russell
Beyer, Paul
Parsonnet, Julie
Chertow, Glenn M.
LANCET, 2020, 396 (10259): : 1335 - 1344
[10] Immediate reactions after mRNA SARS-CoV-2 vaccination
Jeimy, Samira
Wong, Tiffany
Song, Christine
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (48) : E1842 - E1842

← 1 2 3 4 5 →